Long‐term survival following chemoradiation for inoperable non‐small cell lung cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Long‐term survival following chemoradiation for inoperable non‐small cell lung cancer

Published:2008-11 Issue:10 Volume:189 Page:557-559
ISSN:0025-729X
Container-title:Medical Journal of Australia
language:en
Short-container-title:Medical Journal of Australia

Author:

Plumridge Nikki M¹,Millward Michael J²,Rischin Danny³,MacManus Michael P¹,Wirth Andrew¹,Michael Michael³,Yuen Kally⁴,Ball David L¹

Affiliation:

1. Department of Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC.

2. Sir Charles Gairdner Hospital, Perth, WA.

3. Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC.

4. Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, VIC.

Publisher

AMPCo

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.5694/j.1326-5377.2008.tb02179.x

Reference10 articles.

1. Sequential radio‐chemotherapy (RT‐CT) versus radiotherapy alone (RT) and concomitant RT‐CT versus RT alone in locally advanced non‐small cell lung cancer (NSCLC): two meta‐analyses using individual patient data (IPD) from randomised clinical trials (RCTs) [abstract];Rolland E;J Thorac Oncol,2007

2. Concomitant radio‐chemotherapy (RT‐CT) versus sequential RT‐CT in locally advanced non‐small cell lung cancer (NSCLC): a meta‐analysis using individual patient data (IPD) from randomised clinical trials (RCTs) [abstract];Auperin A;J Thorac Oncol,2007

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of Safety and Efficacy of Salvage Therapy With Sunitinib, Docetaxel (Tyxan) and Cisplatinum Followed by Maintenance Vinorelbine for Unresectable/Metastatic Nonsmall Cell Lung Cancer;Medicine;2015-12

2. Curing Non–Small Cell Lung Cancer With Radiotherapy: No Longer an Oxymoron;Seminars in Radiation Oncology;2015-04

3. Long-term survivors in advanced non-small cell lung cancer treated sequentially with cytostatic drugs and erlotinib: A retrospective study;Journal of Translational Internal Medicine;2014-06-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3